[go: up one dir, main page]

GB201617866D0 - Novel formulations - Google Patents

Novel formulations

Info

Publication number
GB201617866D0
GB201617866D0 GBGB1617866.7A GB201617866A GB201617866D0 GB 201617866 D0 GB201617866 D0 GB 201617866D0 GB 201617866 A GB201617866 A GB 201617866A GB 201617866 D0 GB201617866 D0 GB 201617866D0
Authority
GB
United Kingdom
Prior art keywords
novel formulations
formulations
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1617866.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arecor Ltd
Original Assignee
Arecor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arecor Ltd filed Critical Arecor Ltd
Priority to GBGB1617866.7A priority Critical patent/GB201617866D0/en
Publication of GB201617866D0 publication Critical patent/GB201617866D0/en
Priority to CN201780060340.5A priority patent/CN109789088A/en
Priority to JP2019517968A priority patent/JP2019529506A/en
Priority to EP23173389.0A priority patent/EP4265296A3/en
Priority to IL265609A priority patent/IL265609B2/en
Priority to US16/337,706 priority patent/US12527845B2/en
Priority to PCT/GB2017/052940 priority patent/WO2018060735A1/en
Priority to PL17780865.6T priority patent/PL3518892T3/en
Priority to KR1020197011076A priority patent/KR102482664B1/en
Priority to AU2017334289A priority patent/AU2017334289B2/en
Priority to CA3034971A priority patent/CA3034971C/en
Priority to EP17780866.4A priority patent/EP3518893A1/en
Priority to JP2019517947A priority patent/JP7145849B2/en
Priority to US16/337,730 priority patent/US20190282667A1/en
Priority to CN201780060339.2A priority patent/CN109803639B/en
Priority to EP17780865.6A priority patent/EP3518892B1/en
Priority to MX2019003611A priority patent/MX2019003611A/en
Priority to PCT/GB2017/052941 priority patent/WO2018060736A1/en
Priority to AU2017334290A priority patent/AU2017334290B2/en
Priority to CA3034972A priority patent/CA3034972C/en
Priority to ES17780865T priority patent/ES2954180T3/en
Priority to DK17780865.6T priority patent/DK3518892T5/en
Priority to JP2022132329A priority patent/JP2022176989A/en
Priority to JP2022148894A priority patent/JP2022180499A/en
Priority to JP2024110933A priority patent/JP2024153677A/en
Ceased legal-status Critical Current

Links

GBGB1617866.7A 2016-09-29 2016-10-21 Novel formulations Ceased GB201617866D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB1617866.7A GB201617866D0 (en) 2016-10-21 2016-10-21 Novel formulations
DK17780865.6T DK3518892T5 (en) 2016-09-29 2017-09-29 PHARMACEUTICAL FORMULATION CONTAINING AN INSULIN COMPOUND
JP2019517947A JP7145849B2 (en) 2016-09-29 2017-09-29 novel formulation
CN201780060339.2A CN109803639B (en) 2016-09-29 2017-09-29 new preparation
EP23173389.0A EP4265296A3 (en) 2016-09-29 2017-09-29 Pharmaceutical formulation comprising an insulin compound
IL265609A IL265609B2 (en) 2016-09-29 2017-09-29 Aqueous liquid pharmaceutical formulation comprising insulin, ionic zinc, non-ionic surfactant and a medical device comprising the formulation
US16/337,706 US12527845B2 (en) 2016-09-29 2017-09-29 Formulations
PCT/GB2017/052940 WO2018060735A1 (en) 2016-09-29 2017-09-29 Novel formulations
PL17780865.6T PL3518892T3 (en) 2016-09-29 2017-09-29 PHARMACEUTICAL PREPARATION CONTAINING INSULIN COMPOUND
KR1020197011076A KR102482664B1 (en) 2016-09-29 2017-09-29 new formulation
AU2017334289A AU2017334289B2 (en) 2016-09-29 2017-09-29 Novel formulations
CA3034971A CA3034971C (en) 2016-09-29 2017-09-29 A pharmaceutical insulin formulation
EP17780866.4A EP3518893A1 (en) 2016-09-29 2017-09-29 Novel formulations
CN201780060340.5A CN109789088A (en) 2016-09-29 2017-09-29 Novel formulation
US16/337,730 US20190282667A1 (en) 2016-09-29 2017-09-29 Novel formulations
JP2019517968A JP2019529506A (en) 2016-09-29 2017-09-29 New formulation
EP17780865.6A EP3518892B1 (en) 2016-09-29 2017-09-29 Pharmaceutical formulation comprising an insulin compound
MX2019003611A MX2019003611A (en) 2016-09-29 2017-09-29 Novel formulations.
PCT/GB2017/052941 WO2018060736A1 (en) 2016-09-29 2017-09-29 Novel formulations
AU2017334290A AU2017334290B2 (en) 2016-09-29 2017-09-29 Novel formulations
CA3034972A CA3034972C (en) 2016-09-29 2017-09-29 A pharmaceutical insulin formulation
ES17780865T ES2954180T3 (en) 2016-09-29 2017-09-29 Pharmaceutical formulation comprising an insulin compound
JP2022132329A JP2022176989A (en) 2016-09-29 2022-08-23 novel formulation
JP2022148894A JP2022180499A (en) 2016-09-29 2022-09-20 novel formulation
JP2024110933A JP2024153677A (en) 2016-09-29 2024-07-10 New formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1617866.7A GB201617866D0 (en) 2016-10-21 2016-10-21 Novel formulations

Publications (1)

Publication Number Publication Date
GB201617866D0 true GB201617866D0 (en) 2016-12-07

Family

ID=57738021

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1617866.7A Ceased GB201617866D0 (en) 2016-09-29 2016-10-21 Novel formulations

Country Status (1)

Country Link
GB (1) GB201617866D0 (en)

Similar Documents

Publication Publication Date Title
IL273541A (en) Formulations
IL273282A (en) Niraparib formulations
IL269630A (en) Niraparib formulations
IL269621A (en) Niraparib formulations
GB2551985B (en) Novel formulation
IL261792B (en) Compositions
IL260933A (en) Plinabulin compositions
GB201610156D0 (en) Cliptac compositions
IL265609A (en) Novel formulations
GB201513010D0 (en) Novel formulation
GB201607918D0 (en) Novel formulations
EP3373928A4 (en) Novel formulations
GB201419091D0 (en) Formulations
GB201707189D0 (en) Novel formulations
GB201419261D0 (en) Formulations
GB201707188D0 (en) Novel formulations
GB201707187D0 (en) Novel formulations
GB201622161D0 (en) Compositions
GB201614799D0 (en) Compositions
GB201602658D0 (en) Compositions
GB201504482D0 (en) Novel formulations
GB201805338D0 (en) Cosmetic formulations
IL268195A (en) Solid fosmetpantothenate formulations
GB201617866D0 (en) Novel formulations
GB201616509D0 (en) Novel formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)